These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 18312057)
1. Escitalopram in the treatment of impulsive-compulsive internet usage disorder: an open-label trial followed by a double-blind discontinuation phase. Dell'Osso B; Hadley S; Allen A; Baker B; Chaplin WF; Hollander E J Clin Psychiatry; 2008 Mar; 69(3):452-6. PubMed ID: 18312057 [TBL] [Abstract][Full Text] [Related]
2. Citalopram for compulsive shopping disorder: an open-label study followed by double-blind discontinuation. Koran LM; Chuong HW; Bullock KD; Smith SC J Clin Psychiatry; 2003 Jul; 64(7):793-8. PubMed ID: 12934980 [TBL] [Abstract][Full Text] [Related]
3. [Efficacy and tolerability of escitalopram in anxiety disorders: a review]. Pelissolo A Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243 [TBL] [Abstract][Full Text] [Related]
4. A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder. Montgomery SA; Nil R; Dürr-Pal N; Loft H; Boulenger JP J Clin Psychiatry; 2005 Oct; 66(10):1270-8. PubMed ID: 16259540 [TBL] [Abstract][Full Text] [Related]
5. Escitalopram treatment of kleptomania: an open-label trial followed by double-blind discontinuation. Koran LM; Aboujaoude EN; Gamel NN J Clin Psychiatry; 2007 Mar; 68(3):422-7. PubMed ID: 17388713 [TBL] [Abstract][Full Text] [Related]
6. Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation. Grant JE; Potenza MN Int Clin Psychopharmacol; 2006 Jul; 21(4):203-9. PubMed ID: 16687991 [TBL] [Abstract][Full Text] [Related]
7. Escitalopram maintenance treatment for prevention of recurrent depression: a randomized, placebo-controlled trial. Kornstein SG; Bose A; Li D; Saikali KG; Gandhi C J Clin Psychiatry; 2006 Nov; 67(11):1767-75. PubMed ID: 17196058 [TBL] [Abstract][Full Text] [Related]
12. Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse. Hollander E; Stein DJ; Fineberg NA; Marteau F; Legault M J Clin Psychiatry; 2010 Jun; 71(6):784-92. PubMed ID: 20492845 [TBL] [Abstract][Full Text] [Related]
13. Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence. Muhonen LH; Lönnqvist J; Juva K; Alho H J Clin Psychiatry; 2008 Mar; 69(3):392-9. PubMed ID: 18348597 [TBL] [Abstract][Full Text] [Related]
14. Escitalopram in the treatment of obsessive-compulsive disorder. Zohar J Expert Rev Neurother; 2008 Mar; 8(3):339-49. PubMed ID: 18345966 [TBL] [Abstract][Full Text] [Related]
15. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies. Clayton AH; Croft HA; Horrigan JP; Wightman DS; Krishen A; Richard NE; Modell JG J Clin Psychiatry; 2006 May; 67(5):736-46. PubMed ID: 16841623 [TBL] [Abstract][Full Text] [Related]
16. Escitalopram in the treatment of patients with schizophrenia and obsessive-compulsive disorder: an open-label, prospective study. Stryjer R; Dambinsky Y; Timinsky I; Green T; Kotler M; Weizman A; Spivak B Int Clin Psychopharmacol; 2013 Mar; 28(2):96-8. PubMed ID: 23211492 [TBL] [Abstract][Full Text] [Related]
17. Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot study. Pallanti S; Quercioli L; Bruscoli M J Clin Psychiatry; 2004 Oct; 65(10):1394-9. PubMed ID: 15491244 [TBL] [Abstract][Full Text] [Related]
18. A double-blind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder. Baldwin DS; Cooper JA; Huusom AK; Hindmarch I Int Clin Psychopharmacol; 2006 May; 21(3):159-69. PubMed ID: 16528138 [TBL] [Abstract][Full Text] [Related]
19. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder]. Azorin JM; Llorca PM; Despiegel N; Verpillat P Encephale; 2004; 30(2):158-66. PubMed ID: 15107719 [TBL] [Abstract][Full Text] [Related]
20. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial. Stahl SM; Gergel I; Li D J Clin Psychiatry; 2003 Nov; 64(11):1322-7. PubMed ID: 14658946 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]